Kidiamix G

Amino acid solution, the active ingredient in Kidiamix G, is an amino acid solution presented as a solution for injection for parenteral use. It provides a balanced mixture of essential and non‑essential amino acids to support protein synthesis and maintain nitrogen balance in patients receiving parenteral nutrition, particularly those who cannot meet their protein requirements orally or enterally.

GNH USA supplies Kidiamix G as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and clinics worldwide.

Kidiamix G, an amino acid solution used in parenteral nutrition, addresses protein and nitrogen requirements in several clinical situations.

Parenteral nutrition: provides a complete amino acid profile to meet protein and nitrogen needs when oral or enteral intake is insufficient. Critical illness: supports ongoing protein synthesis and helps preserve lean body mass in critically ill patients receiving intensive care. Post‑operative care: supplies essential amino acids to promote wound healing and recovery after major surgery. Severe trauma: aids metabolic recovery by delivering necessary amino acids during catabolic stress.

Common adverse reactions associated with Kidiamix G infusion include:

Common Side Effects: - Phlebitis at infusion site: mild inflammation of the vein. - Hypernatremia: elevated serum sodium levels. - Metabolic alkalosis: shift toward higher blood pH. - Hyperglycemia: increased blood glucose in susceptible patients.

Serious or rare reactions that require immediate medical attention may include:

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity with respiratory compromise. - Electrolyte disturbances: severe hyperkalemia or hypocalcemia. - Hepatic dysfunction: marked elevation of liver enzymes. - Renal impairment: worsening kidney function or oliguria.

Kidiamix G should be used with careful clinical monitoring.

- Assess renal function: adjust infusion rate in patients with renal impairment. - Monitor electrolytes: check serum electrolytes regularly during therapy. - Evaluate hepatic status: watch for changes in liver enzyme levels. - Use aseptic technique: prevent contamination during preparation and administration. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidiamix G may interact with other medications or solutions.

Major Interactions (Avoid): - Concurrent high‑dose potassium supplements: risk of hyperkalemia. - Acidifying agents (e.g., ammonium chloride): may destabilize the amino acid solution.

Moderate Interactions (Monitor Closely): - Diuretics: may alter electrolyte balance and require monitoring. - Insulin therapy: monitor blood glucose as amino acids can affect glucose metabolism. - Other parenteral nutrition components: adjust total nutrient composition to avoid excesses.